Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost-Utility and Cost-Effectiveness of Disease-...
By
Charmi Patel
June 20, 2024
Introduction Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system, leading to various debilitating s...
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs
Insights into Austria’s Pricing and Pharmaceutical Policy
COPD Management: Evidence Report on Ensifentrine
Economics in Clinical Trials: A Guide to Value-Based Decisions
A Cost-Effectiveness Analysis of Emicizumab Treatment in Non-Severe Haemophil...
Evaluating the Impact of Molnupiravir in COVID-19 Treatment
Evaluating the Cost-Effectiveness of Adebrelimab in ES-SCLC
« Previous
1
…
4
5
6
7
8
9
Next »